Oxidative stress is implicated in the pathogenesis of many diseases, including serious ocular diseases, keratoconus (KC) and Fuchs endothelial corneal dystrophy (FECD). Flap endonuclease 1 (FEN1) plays an important role in the repair of oxidative DNA damage in the base excision repair pathway. We determined the association between two single nucleotide polymorphisms (SNPs), c.-441G>A (rs174538) and g.61564299G>T (rs4246215), in the FEN1 gene and the occurrence of KC and FECD. This study involved 279 patients with KC, 225 patients with FECD and 322 control individuals. Polymerase chain reaction (PCR) and length polymorphism restriction fragment analysis (RFLP) were applied. The T/T genotype of the g.61564299G>T polymorphism was associated with an increased occurrence of KC and FECD. There was no association between the c.-441G>A
modality to restore lost vision [28] . FECD is a common cause of corneal transplantation in the United States for patients over 60 [28, 29] . The pathogenesis of this disease is complex and results from the interaction between genetic and environment factors [3, 28] . The disorder is classified into two forms: early and late onset [30] . The early-onset form is rare and begins in early middle age. This form is linked with mutations in COL8A2, which encodes the collagen helix domain of the α2 chain of type VIII collagen, a main component of Descemet's membrane [31, 32] . The late-onset FECD is more common and typically appears in the fifth decade of life [26] . To date, three genes, ZEB1 (TCF8), encoding the zinc finger E-box-binding homeobox 1 transcription factor, SLC4A11, coding for a sodium-borate cotransporter, and LOXHD1, encoding lipoxygenase homology domain 1 were found to be involved in the development of more common late-onset FECD [33] [34] [35] . In addition, several chromosomal loci were associated with late-onset FECD, including FCD1 at 13pTel-13q12.13, FCD2 at 18q21.2-q21.32, FCD3 described at 5q33.1-q35.2 and FCD4 at 9p24.1e22.1 [34, [36] [37] [38] [39] . A linkage study also identified chromosomes 1, 7, 15, 17 and X as potentially involved in the development of FECD [38] .
Genetic factors in KC and FECD were intensively investigated in recent years [9, 28, 40, 41] . In this work, we checked whether polymorphisms of the flap endonuclease 1 (FEN1) gene may be associated with KC or FECD occurrence. FEN1 plays an essential role in the repair DNA damage during long-patch base-excision repair (BER), so changes in its gene may lead to the increased susceptibility of DNA to oxidative injury. The results of several studies indicate a role for oxidative stress in the development of KC and FECD. We hypothesize that the variability in the FEN1 gene may change the susceptibility to oxidative stress and contribute to the development of KC and FECD. To verify this hypothesis, we checked the association between the c.-441G>A (rs174538) and g.61564299G>T (rs4246215) polymorphisms and KC/FECD occurrence, as well as the modulation of this association by some demographic and risk factors for KC/FECD.
Results

Characteristics of Study Subjects
Demographic variables and potential risk factors for KC and FECD of the study patients and controls are shown in Table 1 . There were significantly more subjects with a positive family history for KC and FECD (first degree relatives) among the patients in comparison to controls (11% and 16% vs. 3%, p < 0.001). We showed a significant differences between the distribution of family history for KC/FECD (positive vs. negative family history) and co-occurrence of visual impairment (yes vs. no) among KC/FECD patients and controls. We also demonstrated a significant differences between the distribution of allergies (yes vs. never) and heart or vascular diseases (yes vs. never) and co-occurrence of visual impairment (yes vs. no) among KC patients and controls. These parameters were further adjusted in a multivariate logistic regression model for possible confounding factors of the main effect of the single nucleotide polymorphisms (SNPs). We analysed the relationships between age, sex, tobacco smoking, co-occurrence of visual disturbances, body mass index (BMI), heart and vascular diseases, allergies and KC/FECD in family and the risk of KC/FECD independently of genotype. We compared KC and FECD patients with controls according to these parameters (Tables 2 and 3 ). Male sex, KC in family, co-occurrence of visual disturbances and allergies significantly increased the occurrence of KC, whereas age and co-occurrence of heart and vascular diseases decreased this occurrence. We also found that female sex, age, FECD in family and co-existence of visual disturbances significantly increased the occurrence of FECD. 
The c.-441G>A and the g.61564299G>T Polymorphisms of the FEN1 Gene and KC/FECD Occurrence
The genotype and allele distributions of the c.-441G>A and the g.61564299G>T polymorphisms of the FEN1 gene in KC patients and controls are presented in Table 4 . We observed a significant (p < 0.05) difference in the frequency distributions of genotypes of the g.61564299G>T polymorphism between the cases and controls. The presence of the T/T genotype was associated with an increased occurrence of KC. We did not find any association between genotypes/alleles of the c.-441G>A polymorphism and KC occurrence. Table 5 presents the genotype and allele distributions of the c.-441G>A and the g.61564299G>T polymorphisms of the FEN1 gene in FECD patients and controls. We detected a significant (p < 0.05) difference in the frequency distributions of genotypes of the c.-441G>A polymorphism between the cases and controls. We showed an association between the presence of the T/T genotype of the g.61564299G>T polymorphism and an increase of the occurrence of FECD. We did not detect any correlation between genotypes/alleles of the c.-441G>A polymorphism and FECD occurrence. The observed genotypes frequencies of the g.61564299G>T polymorphism did not deviate statistically significantly from these expected from the Hardy-Weinberg equilibrium, among KC and FECD patients (p > 0.05, data not shown).
Haplotypes and KC/FECD Occurrence
The association between KC/FECD and haplotypes of the c.-441G>A and the g.61564299G>T polymorphisms of the FEN1 gene was also assessed (Table 6 ). The presence of the GG haplotype was associated with increased and the GT haplotype with decreased occurrence of KC. We also detected an association between the AG haplotype and an increased occurrence of FECD. 
Discussion
KC and FECD are eye diseases with a complex aetiology. The pathogenesis of these diseases is still poorly understood, although several studies try to clarify mechanisms of their development and progression. To date, multiple genes were identified as possibly implicated in KC and FECD [9, 28, [40] [41] [42] . In addition, various environmental factors, including chronic eye rubbing, wearing hard contact lenses and atopy of the eye, seem to have a role in the pathogenesis of these diseases [3, 26, 43] .
The analysis of the relationship between some clinical, environmental and life style parameters and the occurrence of KC and FECD independent from genotypes in our study indicated a significant influence of a positive family history of KC and FECD. A strong correlation between KC/FECD family history and KC/FECD occurrence was found in several other studies [9, 44] . A significant association between visual impairment, allergic, heart and vascular disease and KC was also detected. In the present work, we demonstrated a significant correlation between visual impairment and FECD occurrence. These results confirm results obtained in other laboratories [43, [45] [46] [47] .
A growing body of evidence indicates that oxidative stress plays an important role in the pathogenesis of KC and FECD [3, [48] [49] [50] [51] . This hypothesis is supported by an excess of ROS and disturbance in the level of transcripts and/or activities of antioxidant enzymes in KC and FECD corneas compared to controls [3, 48, 49, 51, 52] . In addition, increased levels of oxidant-induced DNA damage in KC and FECD corneas was found, especially in mitochondrial DNA (mtDNA) [2, 3, 53] .
An increased levels of oxidative DNA damage in KC and FECD corneas may be associated with functional changes in DNA repair genes that result in a decrease in the DNA repair capacity. Human cells have multiple DNA repair pathways, including nucleotide excision repair (NER), base-excision repair (BER), mismatch repair (MMR), homologous recombination repair (HRR) and non-homologous end joining (NHEJ).
FEN1 is an important nuclease, which is involved in the repair of non-bulky DNA lesions, including multiple oxidative DNA damage. FEN1 removes bifurcated DNA structures with displaced 5'-single-stranded DNA flaps during long-patch BER [54] . Moreover, this enzyme has 5' to 3' exonuclease and gap-dependent endonuclease activities, owing to its being implicated in the maturation of Okazaki fragments and the rescue of stalled replication forks [55] . FEN1 is also involved in other major DNA metabolic pathways, including resolution of tri-nucleotide repeat sequence-derived secondary structures, maintenance of telomere stability and apoptotic fragmentation of DNA [56] . FEN1 was also detected in the mitochondria, where it participates in mitochondrial DNA (mtDNA) replication and repair. As FEN1 has an important role in numerous DNA metabolic pathways, this enzyme is essential to maintain genome integrity. The functional deficiency of FEN1 may lead to severe genomic instability and an increased mutation rate, contributing to susceptibility to a number of genetic diseases [57] . It was found that the c.-441G>A SNP located in the FEN1 promoter causes changes in promoter activity, whereas the g.61564299G>T SNP is associated with different levels of FEN1 RNA expression [58] . The c.-441G>A and the g.61564299G>T polymorphisms of FEN1 are significantly associated with reduced FEN1 expression and increased DNA damage. It was found that these SNPs increase the risk of developing lung cancer in Chinese populations.
To our knowledge, this is the first study investigating the association of the c.-441G>A and the g.61564299G>T polymorphisms of the FEN1 gene on the occurrence of KC and FECD. We found a significant association between the g.61564299G>T polymorphism of the FEN1 gene and KC risk. The occurrence of KC was significantly increased in patients carrying the T/T genotype, suggesting that the g.61564299G>T polymorphism may play a role in KC. However, we observed no association between the c.-441G>A polymorphism of the FEN1 gene polymorphism and the risk of KC. The T/T genotype of the g.61564299G>T polymorphism was also positively correlated with increased occurrence of FECD. We did not find any association between the c.-441G>A polymorphism of the FEN1 gene and FECD.
Experimental Section
Study Population
Our study was carried out on 279 patients with KC, 255 patients with FECD and 322 individuals with FECD/KC exclusion (controls). They were enrolled in the Department of Ophthalmology, Medical University of Warsaw (Warsaw, Poland). Medical history was obtained from all patients, and none of them had any genetic disease.
The diagnosis of KC was based on clinical signs and pachymetric and topographical parameters on Orbscan and Topographic Modeling System (TMS) corneal topography examinations [4, 59, 60] . The map patterns were carefully interpreted manually in all cases. All subjects underwent ophthalmic examination, including intraocular pressure, slit lamp examination, best-corrected visual acuity, fundus examination, Orbscan corneal topographical and pachymetrical maps (Orbscan IIz, Bausch & Lomb, Rochester, NY, USA) and corneal topography (TMS4, Tomey, Nagoya, Japan).
The diagnosis of FECD was based on clinical signs on the slit lamp examination, including the occurrence of endothelial guttae and corneal oedema. Diagnoses were confirmed by the presence of specific lesions, polymegathism and pleomorphism of the endothelial cells in in vivo confocal microscopy (IVCM) examination [61, 62] . Patients underwent ophthalmic examination, including intraocular pressure, best-corrected visual acuity, fundus examination, slit lamp examination, IVCM and anterior segment optical coherence tomography (AS-OCT), including pachymetry maps. The AS-OCT was performed by Swept Source Anterior Segment Casia OCT (Tomey, Nagoya, Japan). The IVCM was performed by a white light scanning slit confocal microscopy system (ConfoScan 3 or ConfoScan 4, Nidek Techologies, Padova, Italy).
The control subjects showed no clinical evidence of FECD/KC and had healthy corneal endothelium on IVCM and normal corneal pachymetry and topography.
Each individual donated five millilitres of venous blood to EDTA-containing tubes, which were stored at −20 °C.
This study was performed according to the tenets of the Bioethics Committee of the Medical University of Warsaw. All patients gave written informed consent and were interviewed using a structural questionnaire to obtain information on demographic data and potential risk factors for KC and FECD. The data collected included age, BMI, co-occurrence of visual impairment (hyperopia, astigmatism, myopia), heart or vascular diseases, allergy, family history among first degree relatives for KC or FECD and lifestyle habits, including smoking. Smoking was categorized as never smokers and ever smokers. The characteristics of all subjects are presented in Table 1 .
Selection of SNPs and Primer Design
The c.-441G>A and g.61564299G>T polymorphisms of the FEN1 gene were chosen from the public domain of the National Centre for Biotechnology Information at http://www.ncbi.nlm. nih.gov/snp. These SNPs possess a minor allele frequency (MAF) 0.321 and 0.628 in the Caucasian population, respectively (submitter population ID: HapMap-CEU for both http://www.ncbi.nlm.nih. gov/snp). The primers were designed using the published nucleotide sequence in the ENSEMBL database (gene ID ENSG00000168496) and Primer3 software (http://frodo.wi.mit.edu/).
Genotyping
Total genomic DNA was isolated from peripheral blood leukocytes using the commercially available AxyPrep™ Blood Genomic DNA Miniprep kit (Axygen Biosciences, Union City, CA, USA), according to the manufacturer's protocol. The purity and concentration of DNA were determined by taking the optical density (OD) of the samples at 260 and 280 nm, and the DNA was stored in TE buffer (5 mM Tris-HCl, 0.1 mM EDTA, pH 8.5), at −20 °C until use. Digested products were evaluated on an 8% polyacrylamide gel. GeneRuler™ 100 bp (Fermentas, Hanover, MD, USA) or the ΦX174 DNA/BsuRI Marker (Fermentas, Hanover, MD, USA) was used as a molecular mass marker. Electrophoresis was carried out at 5 V/cm in TBE buffer and analysed under UV light following ethidium bromide staining. All PCR amplifications were conducted in a C1000 Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, USA). Positive and negative (no template) controls were included in all sets. The accuracy of the genotyping was evaluated by performing duplicate analysis of 10% of samples, and the results were 100% concordant.
Statistical Analysis
To compare the distributions of demographic variables and selected risk factors between patients and controls, the chi-square (χ 2 ) test was used. The Hardy-Weinberg equilibrium was checked using the χ 2 test to compare the observed and expected genotype frequencies. The χ 2 analysis was also used to test the significance of the differences between distributions of genotypes and alleles in KC/FECD patients and controls. The association between case-control status and each polymorphism, measured by the odds ratio (OR) and its corresponding 95% confidence interval (CI), was estimated using an unconditional multiple logistic regression model, both with and without adjustment for age, sex, co-occurrence of visual impairment, allergies, heart or vascular diseases and family status of KC/FECD. Statistical analysis was performed using the SigmaPlot software, version 11.0 (Systat Software, Inc., San Jose, CA, USA).
Conclusions
Our results suggest that the g.61564299G>T polymorphism of the FEN1 gene may be associated with susceptibility to KC and FECD and be considered as markers in these diseases.
